Skip to content

13F-HR/A filed by Ghost Tree Capital, LLC

Ghost Tree Capital, LLC filed this 13F-HR/A for the quarter ended 2015-06-30, filed 2015-09-09, with 69 holding rows worth $308,610,000.

Accession
0001140361-15-034669
Filed
2015-09-09
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2015

A holdings report, amendment of type restatement, 69 entries on the cover page, a total value of $308,610,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $308,610,000 with VALUE read as thousands by filing date, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ALLERGAN PLCG0177J108SHS45,000$13,656,000thousands by filing date
FLAMEL TECHNOLOGIES-SP ADR338488109SPON575,000$12,184,000thousands by filing date
BIOGEN INC COM09062X103Stock30,000$12,118,000thousands by filing date
NUVASIVE INC670704105COM235,000$11,134,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock90,000$10,788,000thousands by filing date
FIVE PRIME THERAPEUTICS INC.33830X104Common Stock425,000$10,557,000thousands by filing date
Intuitive Surgical,Inc.46120E602COM20,000$9,690,000thousands by filing date
ENDO INTL PLCG30401106SHS120,000$9,558,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS75,000$9,213,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM50,000$9,039,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock170,000$7,744,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM60,000$7,409,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS200,000$6,948,000thousands by filing date
GENMARK DIAGNOSTICS INC372309104COM750,000$6,795,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM400,000$6,168,000thousands by filing date
ESPERION THERAPEUTICS INC NEW COM29664W105Stock75,000$6,132,000thousands by filing date
CEPHEID15670R107COM100,000$6,115,000thousands by filing date
CIGNA CORPORATION125509109COM37,500$6,075,000thousands by filing date
EPIZYME INC29428V104COM250,000$6,000,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM122,500$5,851,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM375,000$5,306,000thousands by filing date
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock100,000$5,276,000thousands by filing date
DEXCOM INC COM252131107Stock65,000$5,199,000thousands by filing date
AETNA INC NEW00817Y108COM40,000$5,098,000thousands by filing date
ANACOR PHARMACEUTICALS INC032420101COM65,000$5,033,000thousands by filing date
UNIQURE NVN90064101SHS185,000$4,995,000thousands by filing date
ENDOCHOICE HLDGS INC COM29272U103COM300,000$4,905,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM100,000$4,813,000thousands by filing date
CELLECTIS ADS15117K103COM125,000$4,510,000thousands by filing date
VANDA PHARMACEUTICALS INC921659108COM350,000$4,442,000thousands by filing date
ZELTIQ AESTHETICS INC98933Q108COM150,000$4,421,000thousands by filing date
CYNAPSUS THERAPEUTICS INC23257Y859COM PAR NO PAR262,696$4,279,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK350,000$4,221,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM57,500$4,198,000thousands by filing date
VITAE PHARMACEUTICALS INC92847N103COM289,200$4,164,000thousands by filing date
WRIGHT MED GROUP INC98235T107COM150,000$3,939,000thousands by filing date
Alcobra LtdM2239P109SHS600,000$3,924,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328601COM NEW1,250,000$3,763,000thousands by filing date
GENOCEA BIOSCIENCES INC372427104COM270,000$3,707,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM175,000$3,371,000thousands by filing date
Elevance Health, Inc.036752103COM20,000$3,283,000thousands by filing date
ROCKWELL MED INC774374102COM200,000$3,224,000thousands by filing datecall
KEMPHARM INC COM NEW488445107Stock175,000$3,215,000thousands by filing date
Lion Biotechnologies53619R102COM350,000$3,210,000thousands by filing date
THERAPEUTICSMD INC88338N107COM400,000$3,144,000thousands by filing date
AXOVANT SCIENCES LTDG0750W104COM135,000$2,751,000thousands by filing date
FOAMIX PHARMACEUTICALS LTDM46135105SHS250,000$2,563,000thousands by filing date
AVALANCHE BIOT05337G107Common Stock150,000$2,436,000thousands by filing datecall
BIODELIVERY SCIENCES INTL IN09060J106COM300,000$2,388,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM31,700$2,314,000thousands by filing datecall
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK17,500$2,043,000thousands by filing date
TONIX PHARMACEUTICALS HOLDING890260201COM NEW202,500$1,816,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW25,000$1,693,000thousands by filing date
VERSARTIS INC92529L102COM100,000$1,522,000thousands by filing date
ADAPTIMMUNE THERAPEUTICS PLC00653A107SPONDS ADR76,850$1,409,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR63,739$1,127,000thousands by filing date
UNILIFE CORP NEW90478E103COM450,000$968,000thousands by filing date
VERACYTE INC COM92337F107Stock78,386$873,000thousands by filing date
BIODELIVERY SCIENCES INTL IN09060J106COM106,200$845,000thousands by filing datecall
NIVALIS THERAPEUTICS INC65481J109COM50,000$758,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock45,000$672,000thousands by filing date
KINDRED BIOSCIENCES INC COM494577109Stock93,500$638,000thousands by filing date
BIOLASE INC090911108COMMON STOCK300,000$522,000thousands by filing date
XOMA CORP DEL98419J107COM125,000$485,000thousands by filing date
OCERA THERAPEUTICS INC COM67552A108COM125,000$475,000thousands by filing date
GLAUKOS CORP COM377322102Stock15,000$435,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock37,500$432,000thousands by filing date
Neothetics Inc64066G101COM43,000$387,000thousands by filing date
AVALANCHE BIOT05337G107Common Stock15,000$244,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-15-031964 superseded2015-08-14acceptance time not in the bulk data set
13F-HR/A 0001140361-15-034669this filing2015-09-09acceptance time not in the bulk data set